71. 72. 73. Krotoski, W.A., Knudsen, K., Cogswell, F.B., and Conard, R.A. Efficacy of mebendazole against the helminth parasites of a Pacific Island popula- tion. Presented at 28th Annu. Meet. Am. Soc. Tropical Med. and Hyg., Tucson, AZ, Nov. 1979. Krotoski, W.A., Cogswell, F.B., Conard, R.A., and Pratt, H.S. Comparison between mebendazole and pyrantel pamoate against the helminth parasites of two Pacific Island populations. Presented at 15th Annu. Meet. USPHS Professional Assoc., Houston, TX, May 1980. Storch, G.A., Gunn, R.A., Martin, W.T., Pollard, R.A., and Sinclair, S.P,. Shigellosis in the Marshall Islands: Epidemiologic aspects of an outbreak. Am. J. Trop. Med. Hyg. 29: 456-63 (1980). 74, West, K.M. 75. Zimmet, P. 76. Zimmet, P.Z. and Taft, P. The high prevalance of diabetes mellitus on a Central Pacific Island, in: Epidemiology of Diabetes, M. Miller and P.H. Bennett, Eds., Academic, New York, 1976. Zimmet, P.Z. et al. High prevalence of hyperuremia and gout in an 77, Diabetes in American Indians and other native populations of the New World. Diabetes 23: 841 (1974). et al. Pacific Island. The high prevalence of diabetes mellitus on a Central Diabetologia 13: 111 (1977). urbanized Micronesian population. Br. Med. J. 1: 1237 (1978). 78, Zimmet, P. and Whitehouse, S. The effect of age on glucose tolerance: Studies in a Micronesian population with a high prevalence of diabetes. 79, Prior, 80. Prior, I.A.M. A health survey in a rural Maori community with particu~ lar emphasis on cardiovascular, nutritional, and metabolic findings. 81. 82, 83. 84. 85. 86. 87. Diabetes 28: 617 (1979). I.A.M. et al. a Polynesian people. Hyperuricaemia, gout and diabetic abnormality in Lancet 1: 333 (1966). New Zealand Med. J. 61: 333 (1962). Brill, A.B., Tomonaga M., and Heyssel, R.M. exposure to ionizing radiation. Leukemia in man following Ann. Int. Med. 56: 590-609 (1962). Ichimaru, M., Ishimaru, T., and Belsky, J.L. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950-71: Radiation dose, years after exposure, age at expo- sure, and type of leukemia. 10-76). Moloney, W.C. J. Radiat. Res. 19: 262-82 (1978) (RERF TR Leukemia and survivors of atomic bombing. Med. 253: 88-90 (1955). Parker, L., Belsky, J.L., Yamamoto, T., Kawamoto, S., Thyroid carcinoma after exposure to atomic radiation. 80: 600-4 (1974). New Eng. J. and Keehn, R.J. Ann. Int. Med. Manabe, Y., Toyoda, E., and Yamamoto, T. Thyroid carcinoma in atomicbomb survivors of Hiroshima and Nagasaki, 1958-1976. Hiroshima Igaku 314): 421-3 (1978). Hollingsworth, D.R., Hamilton, H.B., Tamagaki, H., and Beebe, G.W. Thyroid disease: A study in Hiroshima, Japan. Medicine (Baltimore) 42: 47 (1963). Sampson, R.J., Key, C.R., Buncher, C.R., and Lijima, S$. Thyroid carci- noma in Hiroshima and Nagasaki, I. autopsy. JAMA 209: 65-70 (1969). =- 93 - Prevalence of thyroid carcinoma at